CME ARTICLEAn Evidence-Based Review of Epidural AdhesiolysisGevirtz, Clifford MD, MPHAuthor Information Dr. Gevirtz is Clinical Associate Professor, Department of Anesthesiology, Louisiana State University-New Orleans, LA, and Medical Director, Somnia Pain Management, 627 West Street, Harrison, NY 10528; E-mail: [email protected]. Dr. Gevirtz has disclosed that he has no significant relationships with or financial interests in any commercial organizations pertaining to this educational activity. The author also has disclosed that the use of hypertonic saline and hyaluronidase with epidural adhesiolysis as discussed in this article has not been approved by the U.S. Food and Drug Administration. All faculty and staff in a position to control the content of this CME activity have disclosed that they have no financial relationships with, or financial interests in, any commercial companies pertaining to this educational activity. Lippincott CME Institute, Inc., has identified and resolved all faculty and staff conflicts of interest regarding this educational activity. Topics in Pain Management: October 2008 - Volume 24 - Issue 3 - p 1-6 doi: 10.1097/01.TPM.0000336595.74003.30 Buy CME Test Metrics Abstract Learning Objectives After reading this article, the practitioner should be able to: Describe the pathophysiology of epidural fibrosis. Explain the strengths and weaknesses of the major prospective trials. Identify four potential complications associated with epidural adhesiolysis. Copyright © 2008 Wolters Kluwer Health, Inc. All rights reserved.